Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,650,290
+$1,140,628 QoQ
Shares Held
184,818
+14.1% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 158 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ZVRA ranks #171 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in ZVRA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,650,290 184,818
2026-03-31 $1,509,662 161,981
2025-12-31 $1,618,337 180,618
2025-09-30 $1,500,345 157,765
2025-06-30 $1,426,929 161,967
2025-03-31 $1,148,449 153,331
2024-12-31 $1,246,863 149,504
2024-09-30 $842,210 121,356
2024-06-30 $540,558 110,318
2024-03-31 $530,178 91,410
2023-12-31 $629,651 96,130
2023-09-30 $435,882 90,432
2023-06-30 $461,203 90,432
2023-03-31 $61,264 11,139
2022-12-31 $51,128 11,139
2022-09-30 $69,507 11,139
2022-06-30 $49,679 11,139
2022-03-31 $383,472 76,237
2021-12-31 $664,024 76,237
2021-09-30 $669,259 71,732
2021-06-30 $919,604 71,732